InsiderClue
Stocks · Technology · Measuring & Controlling Devices, NEC

Niki BioSolutions, Inc.

NIKI Clue Score34
United States Fiscal year ends December CIK 0001734005
$3.02 -24.50% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.02 −48.29% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 17 Jul 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2018Net income−14.8EPS, diluted−0.53Fiscal year 2019Net income−20.1EPS, diluted−0.64Fiscal year 2020Net income4.9EPS, diluted2.00Fiscal year 2021Revenue1.5Net income−25.0 −609.1%EPS, diluted−7.15Fiscal year 2022Revenue1.3 −15.9%Net income−9.8EPS, diluted−2.75Fiscal year 2023Revenue0.4 −66.7%Net income−2.8EPS, diluted−0.62Fiscal year 2024Net income−4.3EPS, diluted−0.78Fiscal year 2025Net income−1.4EPS, diluted−0.19
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a 1.5 1.3 0.4 n/a n/a
Growth −15.9% −66.7%
Net income −14.8 −20.1 4.9 −25.0 −9.8 −2.8 −4.3 −1.4
Growth −609.1%
EPS, diluted −0.53 −0.64 2.00 −7.15 −2.75 −0.62 −0.78 −0.19

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Net margin
Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Net margin−1,624.6%Free cash flow margin−958.9%Fiscal year 2022Net margin−756.2%Free cash flow margin−965.0%Fiscal year 2023Net margin−654.8%Free cash flow margin−1,791.3%Fiscal year 2024Fiscal year 2025
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net margin n/a n/a n/a −1,624.6% −756.2% −654.8% n/a n/a
Free cash flow margin n/a n/a n/a −958.9% −965.0% −1,791.3% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−10.0Capital expenditure−5.6Free cash flow−15.7Fiscal year 2019Operating cash flow−13.4Capital expenditure−0.8Free cash flow−14.2Fiscal year 2020Operating cash flow−15.9Capital expenditure−0.2Free cash flow−16.1Fiscal year 2021Operating cash flow−14.7Capital expenditure−0.1Free cash flow−14.8Fiscal year 2022Operating cash flow−12.3Capital expenditure−0.2Free cash flow−12.5Fiscal year 2023Operating cash flow−7.7Capital expenditure−0.0Free cash flow−7.7Fiscal year 2024Operating cash flow−1.2Fiscal year 2025Operating cash flow−1.8
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −10.0 −13.4 −15.9 −14.7 −12.3 −7.7 −1.2 −1.8
Capital expenditure −5.6 −0.8 −0.2 −0.1 −0.2 −0.0 n/a n/a
Free cash flow −15.7 −14.2 −16.1 −14.8 −12.5 −7.7 n/a n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash12.0Total debt3.4Net cash (debt)8.6Shareholders’ equity33.1Debt to equity0.10Fiscal year 2019Cash5.2Total debt0.3Net cash (debt)4.9Shareholders’ equity16.4Debt to equity0.02Fiscal year 2020Cash3.6Total debt0.3Net cash (debt)3.3Shareholders’ equity41.8Debt to equity0.01Fiscal year 2021Cash8.3Total debt0.3Net cash (debt)8.0Shareholders’ equity23.6Debt to equity0.01Fiscal year 2022Cash5.0Total debt0.1Net cash (debt)4.9Shareholders’ equity15.7Debt to equity0.01Fiscal year 2023Cash2.0Shareholders’ equity24.8Fiscal year 2024Cash0.9Shareholders’ equity21.1Fiscal year 2025Cash3.5Shareholders’ equity23.1
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 12.0 5.2 3.6 8.3 5.0 2.0 0.9 3.5
Total debt 3.4 0.3 0.3 0.3 0.1 n/a n/a n/a
Net cash (debt) 8.6 4.9 3.3 8.0 4.9 n/a n/a n/a
Shareholders’ equity 33.1 16.4 41.8 23.6 15.7 24.8 21.1 23.1
Debt to equity 0.10 0.02 0.01 0.01 0.01 n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a n/a n/a 1.5 1.3 0.4 n/a n/a
Growth −15.9% −66.7%
n/a n/a n/a 1.5 1.2 0.4 n/a n/a
3.1 6.9 11.6 10.9 9.2 5.2 2.2 0.4
4.9 7.4 4.9 5.4 5.2 1.9 0.7 0.6
n/a n/a n/a n/a n/a −4.3 −4.2 −1.4
−14.8 −20.1 4.9 −25.0 −9.8 −2.8 −4.3 −1.4
Growth −609.1%
Per share
n/a −0.64 2.03 −7.15 −2.75 −0.62 −0.78 −0.19
−0.53 −0.64 2.00 −7.15 −2.75 −0.62 −0.78 −0.19
Growth −457.5%
27.9 29.0 3.1 3.5 3.6 4.5 5.5 7.4
27.9 29.0 3.2 3.5 3.6 4.5 5.5 7.4
Growth +3.9% −89.1% +11.1% +1.9% +26.7% +20.6% +34.8%

† The diluted share count jumps at 2020, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 7 of 8 years on file.